Assessment of Colostomy Bags with an Active Chamber Filter System and Incidence of Filter-Related Complication (BREEZE-01)

December 12, 2024 updated by: Salts Healthcare

Three Way Crossover Study: Assessment of Colostomy Bags with an Active Chamber Filter System and Incidence of Filter-Related Complication by People Living with a Colostomy

This 3-way crossover study aims to evaluate whether colostomy bags with an active chamber filter system reduce the incidence of filter-related complications, such as ballooning and pancaking, help neutralise odour, and minimise faecal leakage through the filter compared to colostomy bags with a protective filter

Study Overview

Detailed Description

The study will recruit participants living with a colostomy who experience complications related to colostomy bag filters. The study follows a repeated-measures design, in which each participant will test three types of colostomy bags (A, B, and C) over a 21-day period, divided into three 7-day test periods. During each test period, participants will use one type of colostomy bag for 7-days or up to 21 closed bags. Participants will be instructed to change the colostomy bag as often as they normally would or whenever they deem it necessary

Study Type

Interventional

Enrollment (Estimated)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • England
      • Birmingham, England, United Kingdom, B7 4AA
        • Recruiting
        • Central Skin Sciences Institute (CSSI) Salts Healthcare
        • Contact:
          • Mireille Hamson

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult aged over 18 years
  • Colostomy for 6 months or longer
  • Experiences any filter-related complications, such as ballooning, pancaking, odour, or faecal leakage through the filter, at least once a week (7 days)
  • Independent in colostomy care
  • Using a flat, closed colostomy bag
  • Stoma size (diameter) less than 55 mm
  • Using a colostomy bag with a hydrocolloid wafer (baseplate)
  • Able to read and complete the study questionnaire in English

Exclusion Criteria:

  • Uses colostomy irrigation
  • Bleeding or broken peristomal skin
  • Receiving or had radiotherapy or chemotherapy in the last 2 months
  • Pregnant or breastfeeding
  • Taking part in another clinical study
  • Currently receiving treatment under the care of a stoma clinical nurse specialist

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Confidence Be 1-Piece Closed Bag
The reference device is CE Marked and already commercially available
Active Chamber Filter - Circle Shape
Active Comparator: Confidence Natural 1-Piece Closed Bag
The reference device is CE Marked and already commercially available
Protective Filter - Circle Shape
Active Comparator: Confidence Be go 1-Piece Closed Bag
The reference device is CE Marked and already commercially available in Australia
Active Chamber Filter - Hexagon Shape

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of ballooning
Time Frame: 21-days
Evaluation and comparison of the incidence of ballooning in colostomy bags with active chamber filter system and a protective filter
21-days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of ballooning incidence
Time Frame: 21-days
Evaluation and comparison of the timing of ballooning over a 24-hour period in colostomy bags with an active chamber filter system and a protective filter
21-days
Wear time until ballooning incidence
Time Frame: 21-days
Evaluation and comparison of the wear time duration of colostomy bags with an active chamber filter system and a protective filter until a ballooning incident occurs
21-days
Incidence of pancaking
Time Frame: 21-days
Evaluation and comparison of the incidence of pancaking in colostomy bags with an active chamber filter system and a protective filter
21-days
Time of pancaking incidence
Time Frame: 21-days
Evaluation and comparison of the timing of pancaking incidents over a 24-hour period in colostomy bags with an active chamber filter system and a protective filter
21-days
Wear time until pancaking incidence
Time Frame: 21-days
Evaluation and comparison of the wear time duration of colostomy bags with active chamber filter system and a protective filter until pancaking incident to occur
21-days
Faecal leakage occurrence through the filter
Time Frame: 21-days
Evaluation and comparison of faecal leakage occurrence through the filter in colostomy bags with an active chamber filter system and a protective filter
21-days
Occurrence of odour through the filter
Time Frame: 21-days
Evaluation and comparison of odour occurrence through the filter in colostomy bags with an active chamber filter system and a protective filter
21-days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mireille Hamson, Salt Healthcare

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 29, 2024

Primary Completion (Estimated)

April 30, 2025

Study Completion (Estimated)

April 30, 2025

Study Registration Dates

First Submitted

December 9, 2024

First Submitted That Met QC Criteria

December 12, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 12, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colostomy - Stoma

Clinical Trials on Confidence Be 1-Piece Closed Bag

Subscribe